Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future challenges.

B Sirohi1, R Powles

  • 1Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.

Bone Marrow Transplantation
|October 2, 2007
PubMed
Summary
This summary is machine-generated.

Myeloma treatment has advanced significantly, doubling median survival and improving long-term outcomes. The focus is shifting towards optimizing resources for long-term quality of life in multiple myeloma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asymptomatic Rotator Cuff Tendinopathy in Elderly Diabetics: Is Routine Magnetic Resonance Imaging Evaluation of the Shoulder Warranted?

Malaysian orthopaedic journal·2026
Same author

What constitutes meaningful benefit of cancer drugs in the context of LMICs? A mixed-methods study of oncologists' perceptions on endpoints, benefit, price, and value of cancer drugs.

ESMO open·2024
Same author

ESMO Recommendations on clinical reporting of genomic test results for solid cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

UK Cancer Healthcare Professionals Collaborating With Colleagues in Low- and Middle-Income Countries: Mapping the Extent and Nature of Partnerships; Future Implications.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25-39 Years Old in the UK National Health Service.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same journal

A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.

Bone marrow transplantation·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Clinical Medicine

Background:

  • Multiple myeloma treatment has undergone revolutionary changes over the past 20 years.
  • Current treatment regimens involve chemotherapy, targeted biological therapies, and stem cell transplantation.
  • Significant improvements in median survival and 10-year survival rates have been achieved.

Purpose of the Study:

  • To address the evolving landscape of multiple myeloma care.
  • To identify future challenges in managing multiple myeloma.
  • To explore strategies for optimizing healthcare resource utilization in myeloma treatment.

Main Methods:

  • Review of current treatment paradigms for multiple myeloma.
  • Analysis of survival data and quality of life considerations.

Related Experiment Videos

  • Discussion of resource management in the context of advanced myeloma therapies.

    • Main Results:

    • Patients with multiple myeloma now experience doubled median survival.
    • There is a 20-30% chance of surviving beyond 10 years.
    • The primary focus of care is transitioning to long-term quality of life.

    Conclusions:

    • The advancements in multiple myeloma treatment necessitate a re-evaluation of clinical challenges.
    • Optimizing resource allocation is crucial for sustained patient care and quality of life.
    • Future strategies must balance efficacy with long-term survivorship and resource management.